Results 11 to 20 of about 12,140,521 (311)
Commercial Payors More Likely to Reimburse Unlisted Hip Arthroscopy Procedures Compared With Managed Care but With Similar Overall Dollar Amount. [PDF]
Arthrosc Sports Med RehabilPurpose To compare the reimbursement practices of public managed care (MC) insurance versus private commercial insurance (COM) for hip arthroscopy using the current procedural terminology (CPT) code 29999. Methods The CPT codes and corresponding reimbursements of hip arthroscopies that employed code 29999 performed from January 2020 to December 2024 in
Neufeld EV +4 more
europepmc +2 more sources
The impact of expanding health insurance coverage for anti‐cancer drugs on cancer survival in Korea
Cancer Medicine, 2021 Background To reduce out‐of‐pocket costs, the Korean government expanded health insurance reimbursement in anti‐cancer drugs for cancer patients in 2013.
Do‐Yeon Cho +2 more
doaj +1 more source
대한영상의학회지, 2020 In accordance with the new healthcare policy of government (Moon Jae-In Care) to strengthen health insurance coverage, the National Health Insurance (NHI) coverage of brain magnetic resonance imaging (MRI), brain/neck MR angiography (MRA), and head and
Eunhee Kim
doaj +1 more source
Mayo Clinic Proceedings: Digital Health, 2023 The reimbursement of artificial intelligence (AI)–based medical devices (MDs) is a complex and challenging issue, depending on national market access pathways.
Line Farah, Pharm D +2 more
doaj +1 more source
Reimbursement for injury-induced medical expenses in Chinese social medical insurance schemes: A systematic analysis of legislative documents. [PDF]
PLoS ONE, 2018 Social medical insurance schemes are crucial for realizing universal health coverage and health equity. The aim of this study was to investigate whether and how reimbursement for injury-induced medical expenses is addressed in Chinese legislative ...
Yuyan Gao +5 more
doaj +1 more source
The evolution of Taiwan’s National Health Insurance drug reimbursement scheme [PDF]
DARU Journal of Pharmaceutical Sciences, 2015 The rapid growth of health care expenditures, especially pharmaceutical spending, is a challenge for many countries. To control increasing pharmaceutical expenditures and to enhance rational use of drugs, Taiwan's National Health Insurance drug reimbursement system has evolved over time since its introduction in 1995.
Hsu, Jason C, Lu, Christine
openaire +4 more sources
Journal of Market Access & Health Policy, 2023 Background and objectives: Multiple reforms aimed at improving the Chinese population’s health have been introduced in recent years, including several designed to improve access to innovative drugs. We sought to review current factors affecting access to
Bérengère Macabeo +7 more
doaj +1 more source
Optimal cost reimbursement of health insurers to reduce risk selection [PDF]
Health Economics, 2011 In the absence of a perfect risk adjustment scheme, reimbursing health insurers' costs can reduce risk selection in community-rated health insurance markets. In this paper, we develop a model in which insurers determine the cost efficiency of health care and have incentives for risk selection.
Kifmann, Mathias, Lorenz, Normann
openaire +5 more sources
Can Basic Medical Insurance Reduce Elderly Family Income Inequality in China?
Frontiers in Public Health, 2022 Basic medical insurance is the critical medical security system to realize common prosperity in China. This study explores the impact of basic medical insurance on elderly family income inequality in China using the China Family Panel Studies (CFPS) data
Xiaohong Pu +4 more
doaj +1 more source
Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China
Chinese Medical Journal, 2016 Background: China has not established social security system for rare diseases. Rare diseases could easily impoverish patients and their families. Little research has studied the equity and accessibility of health services for patients with rare diseases
Xiao-Xiong Xin +3 more
doaj +1 more source